PHK
BMRN icon

Point72 Hong Kong’s BioMarin Pharmaceuticals BMRN Stock Holding History

Point72 Hong Kong’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,764
Closed -$3.45M – 477
2025
Q1 		$3.45M Buy
+48,764
New +$3.28M 0.22% 114
2024
Q2 		– Sell
-9,411
Closed -$822K – 466
2024
Q1 		$822K Buy
+9,411
New +$842K 0.04% 292
2022
Q2 		– Sell
-7,836
Closed -$604K – 1935
2022
Q1 		$604K Buy
7,836
+2,767
+55% +$232K 0.02% 658
2021
Q4 		$448K Buy
+5,069
New +$418K 0.02% 799
2021
Q2 		– Sell
-8,466
Closed -$639K – 1934
2021
Q1 		$639K Buy
+8,466
New +$692K 0.02% 788
2020
Q2 		– Sell
-230
Closed -$19K – 1147
2020
Q1 		$19K Buy
+230
New +$19.8K 0.01% 559
2019
Q3 		– Sell
-1,156
Closed -$99K – 1021
2019
Q2 		$99K Sell
1,156
-70
-6% -$5.99K 0.03% 494
2019
Q1 		$109K Buy
1,226
+1,078
+728% +$99.9K 0.04% 345
2018
Q4 		$13K Sell
148
-903
-86% -$85.9K 0.01% 504
2018
Q3 		$102K Buy
1,051
+1,022
+3,524% +$102K 0.03% 335
2018
Q2 		$3K Buy
+29
New +$2.54K ﹤0.01% 739
2018
Q1 		– Sell
-1,400
Closed -$125K – 905
2017
Q4 		$125K Buy
+1,400
New +$122K 0.1% 88
2017
Q3 		– Sell
-560
Closed -$51K – 812
2017
Q2 		$51K Buy
+560
New +$50.9K 0.05% 216
2016
Q4 		– Sell
-14,210
Closed -$1.31M – 865
2016
Q3 		$1.31M Buy
+14,210
New +$1.34M 0.72% 27
2016
Q2 		– Sell
-10,051
Closed -$829K – 523
2016
Q1 		$829K Buy
+10,051
New +$818K 1.62% 12
2015
Q4 		– Sell
-294
Closed -$31K – 497
2015
Q3 		$31K Buy
+294
New +$39.3K 0.05% 89
2015
Q1 		– Sell
-421
Closed -$38K – 281
2014
Q4 		$38K Buy
+421
New +$35K 0.04% 410

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's BMRN Position: Q2 2025 in Review

Point72 Hong Kong sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 48,764 shares — an estimated $3.45M sold.

Point72 Hong Kong first reported a position in BMRN in Q4 2014 and held it in 17 quarters. The position peaked at $3.45M in Q1 2025. 582 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • Point72 Hong Kong reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 48,764 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $3.45M.
  • Point72 Hong Kong first reported a position in BioMarin Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Point72 Hong Kong's BioMarin Pharmaceuticals position peaked at $3.45M in Q1 2025.
  • 582 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.